NANOGNB

gene
On this page

Summary

NANOGNB (NANOG neighbor homeobox, HGNC:24958) is a protein-coding gene on chromosome 12p13.31, encoding NANOG neighbor homeobox (Q7Z5D8).

Predicted to enable DNA-binding transcription factor activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.

Source: NCBI Gene 360030 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 30 total
  • MANE Select transcript: NM_001145465

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24958
Approved symbolNANOGNB
NameNANOG neighbor homeobox
Location12p13.31
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000205857
Ensembl biotypeprotein_coding
OMIM620692
Entrez360030

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000382119, ENST00000640040

RefSeq mRNA: 1 — MANE Select: NM_001145465 NM_001145465

CCDS: CCDS44826

Canonical transcript exons

ENST00000382119 — 4 exons

ExonStartEnd
ENSE0000149097177738007774121
ENSE0000149097277704397770518
ENSE0000149097377699837770315
ENSE0000149097477652167765387

Expression profiles

Bgee: expression breadth tissue_specific, 8 present calls, max score 79.43.

Top tissues by expression

112 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047379.43gold quality
colonic epitheliumUBERON:000039742.86silver quality
bone marrow cellCL:000209241.94gold quality
lower esophagus mucosaUBERON:003583441.56silver quality
stromal cell of endometriumCL:000225539.30gold quality
granulocyteCL:000009438.75gold quality
ganglionic eminenceUBERON:000402337.62silver quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
liverUBERON:000210732.30gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
primary visual cortexUBERON:000243631.26gold quality
leukocyteCL:000073831.11gold quality
superior frontal gyrusUBERON:000266131.10silver quality
sural nerveUBERON:001548830.93gold quality
monocyteCL:000057630.76gold quality
urinary bladderUBERON:000125530.56gold quality
lymph nodeUBERON:000002930.42silver quality
vermiform appendixUBERON:000115430.05silver quality
bloodUBERON:000017829.74gold quality
right uterine tubeUBERON:000130229.64gold quality
right lobe of liverUBERON:000111429.09gold quality
tonsilUBERON:000237228.49gold quality
duodenumUBERON:000211428.14gold quality
cortex of kidneyUBERON:000122528.11gold quality
placentaUBERON:000198727.90silver quality
islet of LangerhansUBERON:000000627.45silver quality
metanephros cortexUBERON:001053326.17gold quality
kidneyUBERON:000211326.09gold quality
muscle of legUBERON:000138326.04gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-36552yes166.38
E-ANND-3yes3.61

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

19 targeting NANOGNB, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-6755-5P99.9565.59464
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-5582-3P99.8672.484221
HSA-MIR-139-5P99.8069.501399
HSA-MIR-136-5P99.5067.261153
HSA-MIR-57899.4668.361787
HSA-MIR-56999.4266.321009
HSA-MIR-444398.0266.251928
HSA-MIR-7855-5P97.3967.18925
HSA-MIR-3121-5P97.3066.621146
HSA-MIR-6841-5P97.1967.29409
HSA-MIR-5195-5P90.8465.09287

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriorims2bENSDARG00000102690
drosophila_melanogasterRimFBGN0053547
caenorhabditis_elegansWBGENE00006750

Paralogs (4): RIMS1 (ENSG00000079841), RIMS4 (ENSG00000101098), RIMS3 (ENSG00000117016), RIMS2 (ENSG00000176406)

Protein

Protein identifiers

NANOG neighbor homeoboxQ7Z5D8 (reviewed: Q7Z5D8)

Alternative names: Homeobox protein C14

All UniProt accessions (2): A0A1W2PR93, Q7Z5D8

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Nucleus.

RefSeq proteins (1): NP_001138937* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001356HDDomain
IPR009057Homeodomain-like_sfHomologous_superfamily

Pfam: PF00046

UniProt features (4 total): chain 1, DNA-binding region 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q7Z5D8-F168.240.01

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 16 (showing top): ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ZNF577_TARGET_GENES, MIR548AJ_3P_MIR548X_3P, MIR548AE_3P_MIR548AQ_3P, MIR548AH_3P_MIR548AM_3P, MIR548J_3P, MIR139_5P, MIR7855_5P, WP_PREIMPLANTATION_EMBRYO, ZNF623_TARGET_GENES, ZNF101_TARGET_GENES, ZNF555_TARGET_GENES, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, PULVER_FOREY_PERTURB_ATTRITION_G1_S

GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)

GO Molecular Function (2): DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription2
transcription by RNA polymerase II1
nucleic acid binding1
transcription cis-regulatory region binding1
transcription regulator activity1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

150 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NANOGNBDPRXA6NFQ7721
NANOGNBTPRX1Q8N7U7667
NANOGNBANHXE9PGG2645
NANOGNBARGFXA6NJG6623
NANOGNBDUXBA0A1W2PPF3609
NANOGNBPRAMEF17Q5VTA0604
NANOGNBLEUTXA8MZ59581
NANOGNBPRAMEF20Q5VT98555
NANOGNBDUXAA6NLW8548
NANOGNBRHOXF2BP0C7M4480
NANOGNBCT45A3P0DMU6418
NANOGNBAICDAQ9GZX7395
NANOGNBCT45A10P0DMU9392
NANOGNBCT45A5P0DMU8372
NANOGNBRHOXF2Q9BQY4370
NANOGNBRAX2Q96IS3370

IntAct

2 interactions, top by confidence:

ABTypeScore
NANOGNBPRKCSHpsi-mi:“MI:0915”(physical association)0.400

BioGRID (3): NANOGNB (Two-hybrid), NANOGNB (Proximity Label-MS), NANOGNB (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A0A1B0GVG6, A6NE01, C0H3T6, G3UW99, P0C6L1, P0CT86, P11459, P19507, P31628, P32933, P32934, P32935, P33460, P34493, P46916, P84712, Q02838, Q03328, Q08561, Q09020, Q0ZNK1, Q27976, Q2TBV0, Q3E795, Q4V7B4, Q55H65, Q5H9L2, Q5MJ07, Q5MJ08, Q5MJ09, Q5SY13, Q5T7N2, Q6IPX3, Q6SJ84, Q6SJ91, Q7Z5D8, Q86TU6, Q8IZT9, Q8IZU0, Q8LAX3

Diamond homologs: P49796, Q05481, Q7Z5D8, Q96CB5, Q9NRJ1, A0A2R8Y7D0, Q9P1C3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

30 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance26
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

362 predictions. Top by Δscore:

VariantEffectΔscore
12:7770148:G:GTdonor_gain0.9900
12:7770149:A:Tdonor_gain0.9900
12:7770159:G:GTdonor_gain0.9900
12:7770160:A:Tdonor_gain0.9900
12:7770438:GATAA:Gacceptor_gain0.9900
12:7770166:G:Tdonor_gain0.9800
12:7770166:GAAAA:Gdonor_gain0.9800
12:7770201:A:Gdonor_gain0.9800
12:7770514:ATGAG:Adonor_loss0.9800
12:7770515:TGAG:Tdonor_loss0.9800
12:7770516:GAGGT:Gdonor_loss0.9800
12:7770517:AG:Adonor_loss0.9800
12:7770518:GG:Gdonor_loss0.9800
12:7770519:GTAAG:Gdonor_loss0.9800
12:7770520:T:TCdonor_loss0.9800
12:7773796:ACAG:Aacceptor_loss0.9800
12:7773797:CA:Cacceptor_loss0.9800
12:7773798:A:AGacceptor_gain0.9800
12:7773798:AGA:Aacceptor_loss0.9800
12:7773799:G:GGacceptor_gain0.9800
12:7773794:A:AGacceptor_gain0.9700
12:7773798:AGAT:Aacceptor_gain0.9700
12:7773799:GATG:Gacceptor_gain0.9700
12:7770112:G:GTdonor_gain0.9600
12:7770521:AA:Adonor_loss0.9600
12:7773795:A:Gacceptor_gain0.9600
12:7773799:GAT:Gacceptor_gain0.9600
12:7765384:CAAG:Cdonor_loss0.9500
12:7765385:AAGGT:Adonor_loss0.9500
12:7765386:AGGT:Adonor_loss0.9500

AlphaMissense

1248 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:7770451:T:CF150L0.972
12:7770453:T:AF150L0.972
12:7770453:T:GF150L0.972
12:7770241:T:CF121L0.970
12:7770243:T:AF121L0.970
12:7770243:T:GF121L0.970
12:7770289:T:CF137L0.942
12:7770291:T:AF137L0.942
12:7770291:T:GF137L0.942
12:7770448:T:AW149R0.940
12:7770448:T:CW149R0.940
12:7770295:T:CF139L0.939
12:7770297:T:AF139L0.939
12:7770297:T:GF139L0.939
12:7770242:T:CF121S0.915
12:7770450:G:CW149C0.913
12:7770450:G:TW149C0.913
12:7770452:T:CF150S0.901
12:7770234:G:CW118C0.895
12:7770234:G:TW118C0.895
12:7770440:T:AI146K0.874
12:7770465:G:CR154S0.870
12:7770465:G:TR154S0.870
12:7770440:T:CI146T0.866
12:7770284:T:CL135P0.858
12:7770303:G:AM141I0.856
12:7770303:G:CM141I0.856
12:7770303:G:TM141I0.856
12:7770315:G:CQ145H0.855
12:7770315:G:TQ145H0.855

dbSNP variants (sampled 300 via entrez): RS1000835827 (12:7773801 T>A), RS1000971987 (12:7768059 G>A), RS1001024289 (12:7768526 T>C), RS1001194405 (12:7766074 G>C,T), RS1001289355 (12:7773999 G>C), RS1001568968 (12:7766242 G>T), RS1001717234 (12:7772698 A>G), RS1001822098 (12:7772345 T>C), RS1002177342 (12:7768817 C>A), RS1002781734 (12:7763420 C>A), RS1002840378 (12:7771322 A>C,G,T), RS1003037829 (12:7766006 A>T), RS1003244282 (12:7763686 C>G,T), RS1003282182 (12:7767810 G>A), RS1003895223 (12:7773735 T>A,C)

Disease associations

OMIM: gene MIM:620692 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

4 total (human), top 4 by PubMed support.

ChemicalActions (top 5)PubMed papers
hydroxyhydroquinoneincreases expression1
benzo(e)pyreneincreases methylation1
Benzo(a)pyreneaffects methylation1
Methapyrileneincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.